OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiohydantoins as anti-leishmanial agents: n vitro biological evaluation and multi-target investigation by molecular docking studies
Priscila Goes Camargo, Bruna Taciane da Silva Bortoleti, Marciéli Fábris, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 7, pp. 3213-3222
Closed Access | Times Cited: 23

Showing 23 citing articles:

Development of Novel 1,3-Disubstituted-2-Thiohydantoin Analogues with Potent Anti-Inflammatory Activity; In Vitro and In Silico Assessments
Salma M. Khirallah, Heba M. M. Ramadan, Ahmed M. Shawky, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6271-6271
Open Access | Times Cited: 30

Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 16

Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors
Priscila Goes Camargo, Carine Ribeiro dos Santos, Magaly Girão Albuquerque, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Antileishmanial Activity of 4,8-Dimethoxynaphthalenyl Chalcones on Leishmania amazonensis
Kaio Maciel de Santiago-Silva, Bruna Taciane da Silva Bortoleti, Laudicéa do Nascimento Oliveira, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1402-1402
Open Access | Times Cited: 11

Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins
Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto‐Pellissier, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109690-109690
Open Access | Times Cited: 13

Novel imidazolium-thiohydantoin hybrids and their Mn(iii) complexes for antimicrobial and anti-liver cancer applications
Lamia A. Ismail, Rozan Zakaria, Eman Hassan, et al.
RSC Advances (2022) Vol. 12, Iss. 44, pp. 28364-28375
Open Access | Times Cited: 9

Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?
Mariana B.C. Brioschi, Elizabeth M. Coser, Adriano C. Coelho, et al.
International Journal of Antimicrobial Agents (2022) Vol. 60, Iss. 2, pp. 106612-106612
Open Access | Times Cited: 8

In silicoapproach identified benzoylguanidines as SARS-CoV-2 main protease (Mpro) potential inhibitors
Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Gabriel Felix da Silva Gomes, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 16, pp. 7686-7699
Closed Access | Times Cited: 8

New Mn(III)/Fe(III) complexes with thiohydantoin-supported imidazolium ionic liquids for breast cancer therapy
Ola A. Abu Ali, Wesam Abd El‐Fattah, Mohammad Y. Alfaifi, et al.
Inorganica Chimica Acta (2023) Vol. 551, pp. 121460-121460
Closed Access | Times Cited: 4

Molecular modeling of indazole-3-carboxylic acid and its metal complexes (Zn, Ni, Co, Fe and Mn) as NO synthase inhibitors: DFT calculations, docking studies and molecular dynamics simulations
Talis Uelisson da Silva, Everton Tomaz da Silva, Karina de Carvalho Pougy, et al.
Inorganic Chemistry Communications (2021) Vol. 135, pp. 109120-109120
Closed Access | Times Cited: 10

Thiohydantoins as Potential Antioxidant Agents: In vitro and in silico evaluation
Priscila Goes Camargo, Marciéli Fábris, Talis Uelisson da Silva, et al.
ChemistrySelect (2021) Vol. 6, Iss. 38, pp. 10429-10435
Closed Access | Times Cited: 9

A recent update on new synthetic chiral compounds with antileishmanial activity
Michele Verboni, Diego Olivieri, Simone Lucarini
Chirality (2022) Vol. 34, Iss. 10, pp. 1279-1297
Open Access | Times Cited: 6

Chemical Composition and In Vitro and In Silico Antileishmanial Evaluation of the Essential Oil from Croton linearis Jacq. Stems
Jesús García Díaz, Julio César Escalona Arranz, Ania Ochoa-Pacheco, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1712-1712
Open Access | Times Cited: 4

Development of New N- and S-substituted-imidazolidin-4-one Analogues with Potent Anti-breast Cancer Activity: In vitro Molecular Docking Assessment
Dalal Nasser Binjawhar, Arwa Sultan Alqahtani, Ola A. Abu Ali, et al.
Current Organic Chemistry (2024) Vol. 28, Iss. 16, pp. 1278-1287
Closed Access

Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 878-878
Open Access

Multitarget Compounds for Neglected Diseases: A Review
Natália Ferreira de Sousa, Gabriela Ribeiro de Sousa, Natanael Teles Ramos de Lima, et al.
Current Drug Targets (2024) Vol. 25, Iss. 9, pp. 577-601
Closed Access

Study of the Anticancer and Antimicrobial Biological Activity of a New Series of Thiohydantoin Derivatives
Qusay Hussein Hays, Dakhil Zughayir Mutlaq
Baghdad Science Journal (2023)
Open Access | Times Cited: 1

Antiparasitary and antiproliferative activities in vitro of a 1,2,4-oxadiazole derivative on Trypanosoma cruzi
Yasmim Mendes Rocha, Emanuel Paula Magalhães, Marlos de Medeiros Chaves, et al.
Parasitology Research (2022) Vol. 121, Iss. 7, pp. 2141-2156
Closed Access | Times Cited: 2

In silico approaches and in vitro assays identify a coumarin derivative as antiviral potential against SARS-CoV-2
Gabriel Felix da Silva Gomes, Priscila Goes Camargo, Kaio Maciel de Santiago-Silva, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 18, pp. 8978-8991
Closed Access | Times Cited: 2

Synthesis of bis-thiohydantoin derivatives as an antiproliferative agents targeting EGFR inhibitory pathway
Alaa A. Hassan, Ashraf A. Aly, Mohamed Ramadan, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1249-1260
Closed Access

Page 1

Scroll to top